Cargando…

Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli

Resistance to amoxicillin-clavulanate, a widely used beta-lactam/beta-lactamase inhibitor combination antibiotic, is rising globally, and yet susceptibility testing remains challenging. To test whether whole-genome sequencing (WGS) could provide a more reliable assessment of susceptibility than trad...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Timothy J., Stoesser, Nicole, Sheppard, Anna E., Abuoun, Manal, Fowler, Philip, Swann, Jeremy, Quan, T. Phuong, Griffiths, David, Vaughan, Alison, Morgan, Marcus, Phan, Hang T. T., Jeffery, Katie J., Andersson, Monique, Ellington, Matt J., Ekelund, Oskar, Woodford, Neil, Mathers, Amy J., Bonomo, Robert A., Crook, Derrick W., Peto, Tim E. A., Anjum, Muna F., Walker, A. Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269502/
https://www.ncbi.nlm.nih.gov/pubmed/32205351
http://dx.doi.org/10.1128/AAC.02026-19
_version_ 1783541773796114432
author Davies, Timothy J.
Stoesser, Nicole
Sheppard, Anna E.
Abuoun, Manal
Fowler, Philip
Swann, Jeremy
Quan, T. Phuong
Griffiths, David
Vaughan, Alison
Morgan, Marcus
Phan, Hang T. T.
Jeffery, Katie J.
Andersson, Monique
Ellington, Matt J.
Ekelund, Oskar
Woodford, Neil
Mathers, Amy J.
Bonomo, Robert A.
Crook, Derrick W.
Peto, Tim E. A.
Anjum, Muna F.
Walker, A. Sarah
author_facet Davies, Timothy J.
Stoesser, Nicole
Sheppard, Anna E.
Abuoun, Manal
Fowler, Philip
Swann, Jeremy
Quan, T. Phuong
Griffiths, David
Vaughan, Alison
Morgan, Marcus
Phan, Hang T. T.
Jeffery, Katie J.
Andersson, Monique
Ellington, Matt J.
Ekelund, Oskar
Woodford, Neil
Mathers, Amy J.
Bonomo, Robert A.
Crook, Derrick W.
Peto, Tim E. A.
Anjum, Muna F.
Walker, A. Sarah
author_sort Davies, Timothy J.
collection PubMed
description Resistance to amoxicillin-clavulanate, a widely used beta-lactam/beta-lactamase inhibitor combination antibiotic, is rising globally, and yet susceptibility testing remains challenging. To test whether whole-genome sequencing (WGS) could provide a more reliable assessment of susceptibility than traditional methods, we predicted resistance from WGS for 976 Escherichia coli bloodstream infection isolates from Oxfordshire, United Kingdom, comparing against phenotypes from the BD Phoenix (calibrated against EUCAST guidelines). A total of 339/976 (35%) isolates were amoxicillin-clavulanate resistant. Predictions based solely on beta-lactamase presence/absence performed poorly (sensitivity, 23% [78/339]) but improved when genetic features associated with penicillinase hyperproduction (e.g., promoter mutations and copy number estimates) were considered (sensitivity, 82% [277/339]; P < 0.0001). Most discrepancies occurred in isolates with MICs within ±1 doubling dilution of the breakpoint. We investigated two potential causes: the phenotypic reference and the binary resistant/susceptible classification. We performed reference standard, replicated phenotyping in a random stratified subsample of 261/976 (27%) isolates using agar dilution, following both EUCAST and CLSI guidelines, which use different clavulanate concentrations. As well as disagreeing with each other, neither agar dilution phenotype aligned perfectly with genetic features. A random-effects model investigating associations between genetic features and MICs showed that some genetic features had small, variable and additive effects, resulting in variable resistance classification. Using model fixed-effects to predict MICs for the non-agar dilution isolates, predicted MICs were in essential agreement (±1 doubling dilution) with observed (BD Phoenix) MICs for 691/715 (97%) isolates. This suggests amoxicillin-clavulanate resistance in E. coli is quantitative, rather than qualitative, explaining the poorly reproducible binary (resistant/susceptible) phenotypes and suboptimal concordance between different phenotypic methods and with WGS-based predictions.
format Online
Article
Text
id pubmed-7269502
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-72695022020-06-09 Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli Davies, Timothy J. Stoesser, Nicole Sheppard, Anna E. Abuoun, Manal Fowler, Philip Swann, Jeremy Quan, T. Phuong Griffiths, David Vaughan, Alison Morgan, Marcus Phan, Hang T. T. Jeffery, Katie J. Andersson, Monique Ellington, Matt J. Ekelund, Oskar Woodford, Neil Mathers, Amy J. Bonomo, Robert A. Crook, Derrick W. Peto, Tim E. A. Anjum, Muna F. Walker, A. Sarah Antimicrob Agents Chemother Mechanisms of Resistance Resistance to amoxicillin-clavulanate, a widely used beta-lactam/beta-lactamase inhibitor combination antibiotic, is rising globally, and yet susceptibility testing remains challenging. To test whether whole-genome sequencing (WGS) could provide a more reliable assessment of susceptibility than traditional methods, we predicted resistance from WGS for 976 Escherichia coli bloodstream infection isolates from Oxfordshire, United Kingdom, comparing against phenotypes from the BD Phoenix (calibrated against EUCAST guidelines). A total of 339/976 (35%) isolates were amoxicillin-clavulanate resistant. Predictions based solely on beta-lactamase presence/absence performed poorly (sensitivity, 23% [78/339]) but improved when genetic features associated with penicillinase hyperproduction (e.g., promoter mutations and copy number estimates) were considered (sensitivity, 82% [277/339]; P < 0.0001). Most discrepancies occurred in isolates with MICs within ±1 doubling dilution of the breakpoint. We investigated two potential causes: the phenotypic reference and the binary resistant/susceptible classification. We performed reference standard, replicated phenotyping in a random stratified subsample of 261/976 (27%) isolates using agar dilution, following both EUCAST and CLSI guidelines, which use different clavulanate concentrations. As well as disagreeing with each other, neither agar dilution phenotype aligned perfectly with genetic features. A random-effects model investigating associations between genetic features and MICs showed that some genetic features had small, variable and additive effects, resulting in variable resistance classification. Using model fixed-effects to predict MICs for the non-agar dilution isolates, predicted MICs were in essential agreement (±1 doubling dilution) with observed (BD Phoenix) MICs for 691/715 (97%) isolates. This suggests amoxicillin-clavulanate resistance in E. coli is quantitative, rather than qualitative, explaining the poorly reproducible binary (resistant/susceptible) phenotypes and suboptimal concordance between different phenotypic methods and with WGS-based predictions. American Society for Microbiology 2020-05-21 /pmc/articles/PMC7269502/ /pubmed/32205351 http://dx.doi.org/10.1128/AAC.02026-19 Text en Copyright © 2020 Davies et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Mechanisms of Resistance
Davies, Timothy J.
Stoesser, Nicole
Sheppard, Anna E.
Abuoun, Manal
Fowler, Philip
Swann, Jeremy
Quan, T. Phuong
Griffiths, David
Vaughan, Alison
Morgan, Marcus
Phan, Hang T. T.
Jeffery, Katie J.
Andersson, Monique
Ellington, Matt J.
Ekelund, Oskar
Woodford, Neil
Mathers, Amy J.
Bonomo, Robert A.
Crook, Derrick W.
Peto, Tim E. A.
Anjum, Muna F.
Walker, A. Sarah
Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli
title Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli
title_full Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli
title_fullStr Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli
title_full_unstemmed Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli
title_short Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli
title_sort reconciling the potentially irreconcilable? genotypic and phenotypic amoxicillin-clavulanate resistance in escherichia coli
topic Mechanisms of Resistance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269502/
https://www.ncbi.nlm.nih.gov/pubmed/32205351
http://dx.doi.org/10.1128/AAC.02026-19
work_keys_str_mv AT daviestimothyj reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT stoessernicole reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT sheppardannae reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT abuounmanal reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT fowlerphilip reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT swannjeremy reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT quantphuong reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT griffithsdavid reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT vaughanalison reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT morganmarcus reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT phanhangtt reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT jefferykatiej reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT anderssonmonique reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT ellingtonmattj reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT ekelundoskar reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT woodfordneil reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT mathersamyj reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT bonomoroberta reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT crookderrickw reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT petotimea reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT anjummunaf reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli
AT walkerasarah reconcilingthepotentiallyirreconcilablegenotypicandphenotypicamoxicillinclavulanateresistanceinescherichiacoli